Methyl-coenzyme M reductase (MCR) catalyzes the reversible reduction of methyl-coenzyme M (CH 3 -S-CoM) and coenzyme B (HS-CoB) to methane and heterodisulfide CoM-S-S-CoB (HDS). MCR contains the hydroporphinoid nickel complex coenzyme F 430 in its active site, and the Ni center has to be in its Ni(I) valence state for the enzyme to be active. Until now, no in vitro method that fully converted the inactive MCR silent -Ni(II) form to the active MCR red1 -Ni(I) form has been described. With the potential use of recombinant MCR in the production of biofuels and the need to better understand this enzyme and its activation process, we studied its activation under nonturnover conditions and achieved full MCR activation in the presence of dithiothreitol and protein components A2, an ATP carrier, and A3a. It was found that the presence of HDS promotes the inactivation of MCR red1 , which makes it essential that the activation process is isolated from the methane formation assay, which tends to result in minimal activation rates. Component A3a is a multienzyme complex that includes the mcrC gene product, an Fe-protein homolog, an iron-sulfur flavoprotein, and protein components involved in electron bifurcation. A hypothetical model for the cellular activation process of MCR is presented.
T
he highest heat of combustion per mass unit (55.7 kJ/g) among all the hydrocarbons makes methane an important source of clean renewable energy (1) . At the same time, it is also a potent greenhouse gas, with surplus methane production in the geological cycle leading to a slow increase in atmospheric methane concentrations. Understanding the mechanism of methane formation and activation is important for controlling methane emission and improvement of the production of alternative fuels in the form of natural gas. Methyl-coenzyme M reductase (MCR) is the central enzyme in biological methane formation by methanogenic Archaea and consumption by anaerobic methanotrophs (2) (3) (4) . For the methane production, it catalyzes the exergonic conversion of methyl coenzyme M (CH 3 MCR is composed of three different subunits, ␣, ␤, and ␥, forming an (␣␤␥) 2 heterohexamer (5) . Each molecule of MCR contains two molecules of the cofactor F 430 , a Ni-porphinoid, as a prosthetic group (6) (7) (8) . The binding sites of two coenzymes F 430 are roughly 50 Å apart, forming two separated structurally identical active sites. The active-site region of MCR contains five posttranslationally modified (PTM) amino acids (5, 9) comprising 1-N-methyl-His␣ 257 , S-methyl-Cys␣ 452 , 5-methyl-Arg␣ 71 , and 2-methyl-Gln␣ 400 , and thio-Gly␣ 445 . The role of these modifications is not known. In addition, MCR has been subjected to numerous spectroscopic and crystallographic studies. Despite this, the details of the catalytic mechanism are still not clear (10) (11) (12) (13) .
It is well established that the MCR red1 -Ni(I) form is active, while the other two major forms that can be detected in purified enzyme and whole cells, MCR ox1 -Ni(III) and MCR silent -Ni(II), are inactive (14) (15) (16) (17) (18) . The MCR red1 form can be obtained by incubating Methanothermobacter marburgensis cells either with H 2 or CO (15, 19) ; however, it is extremely O 2 sensitive due to the low midpoint potential of the Ni(II)/Ni(I) couple in F 430 , which is estimated to be around Ϫ650 mV (versus a hydrogen electrode; pH 7) (20) . Moreover, the MCR ox1 form can be converted to the MCR red1 form by incubating it with the reductant Ti(III) citrate (17) . In order to study the reaction mechanism or to explore the role of the PTMs, it is important to develop a cell-free system capable of activating inactive MCR. No cell-free system that can fully convert MCR silent to MCR red1 has been reported to date. Small amounts of activation, however, were reported using cellular components purified directly from cell extract using column chromatography (21, 22) . In the first fractionation step, three fractions were discovered: A, an unknown fraction; B, which turned out to be HS-CoB; and C, MCR itself. Fraction A was further fractionated and contained A1, an F 420 -reducing hydrogenase; A2, an ATP-binding protein; A3a, an uncharacterized ironcontaining protein; and A3b, a methyl-viologen-reducing (F 420 -nonreducing) hydrogenase. The activation of MCR was measured by detecting methane formation in the headspace of a closed bottle containing a solution with Ti(III) citrate, component A2, MCR, the column fraction containing A3a, ATP, CH 3 -S-CoM, and HS-CoB. A maximum activity of ϳ0.1 mol min Ϫ1 mg Ϫ1 was obtained (21) (22) (23) . Since then, methods have been established to preserve the active form of MCR during cell harvesting, preparation of cell extract, and subsequent protein purification procedures (14) (15) (16) (17) (18) . In this case, enzyme can be obtained with a specific activity of up to 100 mol min Ϫ1 mg Ϫ1 (17) . The low activity obtained upon activation makes it clear that the activation process is not well understood. It is possible that the small amount of activation was due to the presence of traces of MCR ox1 that can be activated in the presence of Ti(III) citrate. It is also possible that not all essential components were present. Most importantly, we want to know what exactly A3a is. Here, we report the complete activation of MCR ox1 and 65% activation of MCR silent under nonturnover conditions in the presence of dithiothreitol (DTT; E m ϭ Ϫ320 mV) with components A2 and A3a. This is the first time activation of the silent form was achieved with an electron source with a midpoint potential higher than that of the H 2 /H ϩ couple, which is estimated to be Ϫ414 mV under growth conditions. A3a was found to be a multienzyme complex, and a model is presented on how all the components could work together to provide the low-potential electrons needed to reduce the active-site nickel ions in MCR.
MATERIALS AND METHODS
Cloning, expression, and purification of component A2 (atwA). The gene coding for AtwA was generated by amplifying the atwA gene directly from lysed Methanothermobacter marburgensis cells by PCR using the forward primer CATGGATCCATGTCTTTCATAAAGCTGGAAAACG containing a BamHI (underlined) site and the reverse primer CATAAGC TTGGTTATTCCCTGAGCATCCCCC containing a HindIII (underlined) site with the high-fidelity thermostable DNA polymerase Pfu (Agilent Technologies, Clara, CA). The primers were purchased from Integrated DNA Technologies (San Jose, CA), and the restriction enzymes were purchased from New England BioLabs (Ipswich, MA). The resulting PCR product was digested with BamHI and HindIII and ligated into a BamHI-HindIII-digested pQE-80L vector (Qiagen, Valencia, CA). Expression will generate a protein that is tagged at the N terminus with six histidine residues. The recombinant plasmid pQE80-L-atwA was transferred into Escherichia coli strain DH10B by electroporation. The integrity of the recovered plasmid was confirmed by restriction endonuclease digestion and sequencing of the atwA inserts using a universal T5-promoter primer (Qiagen, Valencia, CA). E. coli DH10B cells harboring a pQE-80L-atwA plasmid were grown in the LB medium supplemented with ampicillin (100 g/ml) at 37°C with shaking (at 250 rpm) to an A 600 of 0.5; then, isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to reach a final concentration of 1 mM. The cells were incubated for a further 5 h before being lysed to purify recombinant A2. The A2 protein was purified by immobilized metal affinity chromatography using a 5 ml Ni-Sepharose column (GE Healthcare) connected to an Äkta fast protein liquid chromatography (FPLC) system. The cell pellet from a 1 liter of E. coli DH10B culture harboring the pQE-80L-atwA plasmid was resuspended in 80 ml 50 mM Tris-HCl buffer (pH 8) with 100 mM NaCl (buffer A). Cells were lysed by sonication followed by centrifugation at 20,000 ϫ g for 30 min at 4°C to collect cell extract (CFE). The supernatant containing the A2 protein was filtered using a 0.22-m-pore-size filter unit and loaded on the Ni-Sepharose column. The protein was then eluted using a linear imidazole gradient from 0% to 100% buffer B containing 50 mM Tris-HCl (pH 8), 100 mM NaCl, and 500 mM imidazole. The fractions containing the pure A2 protein were pooled. Imidazole was removed by repeated concentration and dilution steps with buffer A (3ϫ) using a Centricon centrifugal filter unit (Millipore) with a cutoff of 10 kDa. The protein concentration was determined by the Bradford assay, and the purity was determined by SDS-PAGE and de novo sequencing.
Purification of the A3a protein. Purification was performed under strictly anaerobic conditions at 4°C except for the chromatographic steps, which were performed at room temperature. Cell extracts were routinely prepared from ϳ60 g (wet mass) of M. marburgensis cells that had been freshly harvested under anoxic conditions without special pretreatment of the cell culture. The cells were suspended in ϳ80 ml 50 mM Tris-HCl (pH 7.6) (buffer A). Cells were lysed by sonication followed by centrifugation at 35,000 ϫ g for 30 min to collect CFE. The supernatant was concentrated to 10 ml with an Amicon ultrafiltration unit with a 100-kDa cutoff filter and loaded on a Sephacryl S-300 column equilibrated with buffer B containing 50 mM Tris-HCl (pH 7.6) and 0.1 mM NaCl (buffer B). The protein was eluted with buffer B. The activation of MCR was observed only with the dark-brown-colored high-molecular-mass pool. These fractions were pooled and applied to a phenyl-Sepharose column, followed by elution with a decreasing step gradient of 1.0 mM, 0.8 mM, 0.6 mM, and 0.5 mM NaCl in buffer A. A3a activity was observed in the peak eluted with 0.8 mM NaCl. The fractions with A3a activity were combined, concentrated, and applied to a MonoQ column followed by elution with an increasing salt gradient from 0 to 1 M NaCl in buffer A. The A3a activity was observed in fractions eluted between 0.50 and 0.55 M NaCl. MonoQ fractions with A3a activity were further purified by using a Superdex 200 column equilibrated with buffer B. The A3a protein comes down as a single isolated peak from the Superdex 200 column. The concentration of the A3a protein in the different experiments is expressed in g/liter since an exact molecular weight was not obtained for the multiprotein complex.
Purification of methyl-coenzyme M reductase isoenzyme I. The protein from M. marburgensis was purified as described previously (14) . The protein concentration was determined with the Bradford assay (24) with bovine serum albumin (Serva) as a standard or by measuring the absorbance of oxidized enzyme (MCRsilent) at 420 nm using ε ϭ 44,000 M Ϫ1 cm Ϫ1 for a molecular mass of 280,000 Da. Determination of methyl-coenzyme-M reductase activity. Activity of MCR was determined as described previously (17) . Methane formation was detected by withdrawing a gas sample from the headspace of a closed bottle containing 400 l assay solution. The solution contained 500 mM MOPS (morpholinepropanesulfonic acid)/NaOH (pH 7.2), 10 mM methyl-coenzyme M, 1 mM coenzyme B, 0.3 mM aquocobalamin, 30 mM Ti(III) citrate, and purified enzymatic components. Samples were kept on ice. The assay starts by increasing the temperature to 65°C. The assays described here (see Table 2 ) contained 11.2 g MCR (0.1 M) and, when indicated, 0.48 g A2 (0.02 M) and 2.08 g A3a.
Activation of methyl-coenzyme-M reductase. 100 M MCR was incubated for 15 min and 60 min at 60°C in the presence of 20 M component A2, 5.2 mg/ml component A3a, 10 mM MgATP, 5 mM dithiothreitol, and 10 mM methyl-coenzyme.
MS. For protein identification, in-gel tryptic digestion was performed according to the literature (25) . Digested peptides were analyzed using an Acquity ultraperformance liquid chromatography (UPLC) system coupled to a quadrupole-time of flight mass spectrometer (Q-Tof premier; Waters) using electrospray ionization (ESI) in the positive-ion mode operated by Masslynx software (V4.1). Digested peptides were constituted in injection solution (50% methanol and 0.1% formic acid) and eluted from a C 18 reverse phase column (Acquity UPLC BEH C 18 ; Waters) (1.7 m pore size, 2.1 by 50 mm) using a 2% to 40% acetonitrile gradient. Each peptide was registered for the retention time, intensity, m/z, and tandem mass spectrometry (MS/MS) ions. The instrument was calibrated at the time of data acquisition in addition to real-time calibration by the lockmass. Mass accuracy at 5 ppm or less was the key for ensuring the presence of target molecules. Ion source parameters such as the source temperature (gas and sample cone), mobile-phase flow rate, and cone voltage were optimized and fixed throughout the study.
De novo sequencing of the registered peptide ion was performed using the data-dependent acquisition (DDA) method (Waters). Acquired MS/MS fragmentation spectra were interpreted using Proteinlynx software (Proteinlynx Global Servers 2.1; Waters). Protein databases searched were Swiss-Prot, None-Redundant (NCBI), and Marburgensis UniProt, downloaded from UniProt in the FASTA format. The questionable-sequence call was checked occasionally using Biolynx software (Waters).
EPR spectroscopy. Continuous-wave (CW) electron paramagnetic resonance (EPR) spectra were measured at X-band (9-GHz) frequency on a Bruker EMX spectrometer fitted with an ER-4119-HS (high-sensitivity) perpendicular-mode cavity. An Oxford Instrument ESR 900 flow cryostat in combination with a ITC4 temperature controller was used for measurements in the 4-K to 300-K range using a helium flow. Measurements at 77 K were performed by fitting the cavity with a liquid nitrogen finger Dewar.
All spectra were recorded with a field modulation frequency of 100 kHz, a modulation amplitude of 0.6 mT, and a frequency of 9.386 GHz. Samplespecific conditions are indicated in the figure legends.
The EPR signal intensities were determined by measuring the respective EPR-active species under nonsaturating conditions. Since the signals represent the first derivative of the absorption-type signal, the spectra were double integrated and the surface area of each signal, corrected for the presence of two nickel sites per MCR, was compared with that of a 10 mM copper perchlorate standard (10 mM CuSO 4 ; 2 M NaClO 4 ; 10 mM HCl). The values obtained this way were compared to the known enzyme concentration, which was set to 100%. When more than one signal is present, each signal is simulated, the compound spectrum is reproduced, and the double-integration value of each individual component is obtained. The BioEPR package developed by Fred Hagen was used for spectral simulation and double integration of the signals (26) . Only the intensities of the paramagnetic species (red1 and ox1) could be determined as described. The amount of the EPR-inactive form, MCR silent , was assigned as the difference between the concentration of MCR present and the concentration of the paramagnetic species.
RESULTS
Optimization of activation conditions. Activation of MCR in whole cells is a relatively rapid process. Cells that showed minimal amounts of the MCR red1 EPR signal showed a large increase in this signal when the cells were incubated for 5 to 15 min in the presence of 80% H 2 and 20% CO 2 at 65°C (14, 16) . Similar studies performed with cell extracts allowed the evaluation of compounds that could enhance the activation of MCR. Under growth conditions (80% H 2 -20% CO 2 at 65°C), the EPR signal of both MCR red1 and MCR ox1 can be detected in whole cells with EPR spectroscopy (14) . Upon breaking the cells, most of the MCR red1 signal is lost. Fresh cell extract kept at 4°C can be reactivated by incubating the sample under conditions of bubbling with 100% H 2 gas at 60°C. Larger amounts of activation are found when HS-CoM and additional ATP is added (Fig. 1, traces A , B, C, and D). This is in line with earlier studies that showed that MCR red1 can be stabilized by the addition of either coenzyme M or methyl-coenzyme M (27) and that the activation was ATP dependent (22) . CH 3 -S-CoM could also be added with the same effect as observed for coenzyme M (not shown). The addition of HS-CoB, however, consistently resulted in much smaller amounts of activation (Fig. 1, trace E) . In the presence of both HS-CoB and CH 3 -S-CoM, HDS, which is known to inhibit MCR activity, is formed (28) . Some of this could be removed, however, by the effect of the heterodisulfide reductase reaction. The effect of HDS on MCR activity was discovered in activity assays (28) . In the methane formation assay, cobalamin and Ti(III) citrate are added to reduce HDS to the two thiols, coenzyme M and HS-CoB, to prevent the accumulation of HDS.
When fully active MCR in the red1 state was allowed to turn over in the presence of excess CH 3 -S-CoM and HS-CoB, it was observed that the red1 state rapidly disappeared (Fig. 2) . At the same time, there was a less rapid formation of the MCR ox1 form. From the intensities of the EPR signal, it could be calculated that approximately 50% of the red1 form converted into the ox1 form whereas the other half converted into silent forms. It was not possible to repeat this experiment in the presence of Ti(III) citrate due to its EPR signal. The data, however, can be interpreted as indicating that the formed HDS was inactivating MCR. To test this, the direct effect of HDS on MCRred1 was determined by incubating MCRred1 with increasing amounts of HDS and the effect over time was followed using EPR spectroscopy. Figure 3 shows the changes that were detected in the intensity of the MCR red1 EPR signal incubated with different concentrations of HDS for 5 min (Fig. 3A) , 10 min (Fig. 3B ) and 15 min (Fig. 3C) . Comparison of the different figures shows that in the absence of HDS (control), MCR stayed mainly as MCR red1 but the intensity decreased from 86% to 63% after 15 min. In the presence of HDS, however, the red1 form disappeared much faster and the decrease was larger at higher HDS concentrations. Similarly, the formation of MCR ox1 was observed only when HDS was present and a higher intensity was reached with higher HDS concentrations (58% with 20 mM HDS). Over time, however, the MCRox1 signal showed the highest intensity after 5 min, but then the intensity decreased again upon longer incubation. After 15 min, most of the enzyme was converted into one or more silent forms. A possible explanation for the conversion into MCR ox1 would be that HDS binds in the active site and is reduced by the Ni(I), forming the MCR ox1 -Ni(III) form and HS-CoM and HS-CoB. The fact that not all of the red1 state was converted into the ox1 state could indicate that alternative reactions were taking place or could indicate an inherent instability at 60°C of both the ox1 and red1 forms. From these experiments, it can be concluded that the activation process is inhibited by HDS. Therefore, to be able to detect the full activation of MCR, it is important to separate the activation step from the monitoring assay to make sure that HDS formation does not interfere with the activation itself.
The formation of HDS is an important step for Archaea that have a membrane-bound heterodisulfide reductase (HDR) complex. The breakdown of HDS into coenzyme M and coenzyme B using H 2 as an electron source is used to generate a proton gradient that is used for ATP synthesis. In M. marburgensis, however, the HDR complex is not membrane bound but performs an electron bifurcation step to produce essential low-potential electrons (29) . In both cases, one could expect HDS levels to be high to be able to perform these essential processes. Here we show, however, that when levels are too high MCR is inactivated. The hydrogenase:heterodisulfide reductase complex has an apparent K m Ͻ 0.1 mM for CoM-S-S-CoB under bifurcating reaction conditions (29) . This means that the HDS levels can be easily maintained below levels that inactivate MCR without compromising the function of HDR.
Activation of the MCR ox1 and MCR silent forms in the presence of dithiothreitol and activating components A2 and A3a. Both component A2 and component A3a were purified to enable investigation of the mechanism of activation of MCR. To facilitate purification of the A2 protein, a recombinant protein that is tagged at the N terminus with a 6ϫHis tag was constructed. The A2 protein was overexpressed in E. coli and purified from the cell extract using a Ni-Sepharose column. SDS-PAGE analysis of the A2 protein showed a single band at around the expected mass of the protein, 60 kDa (data not shown). For the activation assay, dithiothreitol (E m ϭ Ϫ320 mV) was used instead of Ti(III) citrate (E m ϭ Ϫ500 mV). Since most of our enzyme preparations contained different amounts of MCR ox1 it was important to show that the observed MCR red1 formation was not due to the direct conversion of MCR ox1 into MCR red1 by Ti(III) citrate. Therefore, the assay contained dithiothreitol and purified MCR, component A2, MgATP, and CH 3 -S-CoM. With this assay, the different column fractions were tested for the presence of the A3a component. The The "A3a" spectra are from the A3a fraction (diluted to 5.2 mg/ml). The "activated" samples are the spectra recorded after the activation procedure. The spectra within each panel can be directly compared. The spectra in the different panels are drawn on different scales. EPR conditions: microwave power to the cavity, 2 mW. purification procedure started with a size-exclusion Sephacryl-300 column purification step, followed by a hydrophobic interaction phenyl-Sepharose column step, an anion exchange MonoQ column step, and a size-exclusion Superdex 200 column step. The A3a protein comes down as a single isolated peak from the Superdex column. Figure 4 shows the activation achieved with this A3a preparation. Figure 4A shows how an enzyme preparation containing a mixture of 5% red1 and 70% ox1 (and the rest MCR silent ) is converted into a sample containing 100% MCR red1 . This means that both the ox1 and silent forms were fully converted into the red1 form. Panel B of Fig. 4 shows how a sample that contained only trace amounts of MCR ox1 (5.9%) was converted into a sample containing 69% MCR red1 . No activation was observed in the absence of A2 or A3a protein (data not shown). These data show that the MCR ox1 -Ni(III) form and the MCR silent -Ni(II) form can be converted into the MCR red1 -Ni(I) form by the same activating system. The amount of activation is also unprecedented, being close to 63% activation for the silent-to-red1 conversion.
Effect of HDS on activation and activity of MCR. The direct effects of HS-CoB and HDS on activation were measured. Activation assays were set up for 60 min, and samples were withdrawn at 15 min and 60 min for EPR and activity measurements (Tables 1  and 2 ). In spite of the presence of all the necessary components required for activation, there was no observable formation of the active MCR red1 form in the presence of either HDS or both HDS and HS-CoB at 15 or 60 min. On the other hand, 100% of the red1 form was formed after 15 min under the normal assay conditions and the level decreased to 56.9% at 60 min. This decrease was probably due to heat instability of the enzyme. In the presence of HS-CoB (causing turnover due to the presence of CH 3 -S-CoM and therefore the formation of HDS), the signal intensities reached were only 83.6% at 15 min and 0% at 60 min. The activity of the activated enzyme was determined. We found only 51 mol min Ϫ1 mg Ϫ1 (Table 2) , which is less than the expected value of 100 mol min Ϫ1 mg Ϫ1 (17) . Assuming that there was only one red1 form, it is not clear why this was a lower value.
Characterization of the A3a protein. The purified A3a protein was brown in color, and the electronic absorption spectrum revealed a broad absorbance maximum at 420 nm. After reduction with dithionite, the absorption at 420 nm decreased, a property characteristic of proteins containing Fe-S clusters (data not shown). Similarly, the reduced enzyme showed a broad signal in EPR spectroscopy that can be assigned to the presence of reduced [4Fe-4S] clusters (not shown). The protein, however, is a multienzyme complex, and several of the component enzymes contain iron-sulfur clusters. Further characterization of A3a using SDS-PAGE (Fig. 5) followed by de novo sequencing showed the presence of both F 420 -reducing hydrogenase (Frh) and F 420 -nonreducing hydrogenase (Mvh), polyferredoxin, heterodisulfide reductase (Hdr), tungsten-containing (Fwd) and molybdenumcontaining (Fmd) formylmethanofuran dehydrogenase, methyl coenzyme M reductase operon protein C I (McrC or McrE) and II (MtrC2), acetyl-conenzyme A (CoA) decarbonylase/synthase (Cdh), 5,10-methylenetetrahydro-methanopterin reductase (Mer), Fe-protein homolog/iron sulfur cluster carrier protein (Iscc), predicted iron sulfur flavoprotein (Pisf), and UPF0145 protein MTBMA (Fig. 5 and Table 3 ). When the A3a fraction was applied to a native gel, three bands were observed at around 700 kDa, 160 kDa, and 40 kDa (not shown). It is not clear how these make up the whole protein complex. Most likely the smaller bands represented breakdown products of the 700-kDa complex, since these bands are not observed with size exclusion chromatography. This would also be in line with the previous work that indicated a mass of 500 kDa for the complex purified from Methanobacterium thermoautotrophicum (Methanothermobacter thermoautotrophicus strain ⌬H) (30) . Although this result would indicate that further fractionation could be possible, attempts to purify a smaller complex still capable of activating MCR were not successful. Different procedures, including incubations with 50 mM CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate} or 0.2 M urea, provided different fractions, but the SDS-PAGE showed very little variation in the complex composition. In addition, the activation activity was lost and it was not possible to recombine fractions and restore this activity. The coelution of the complex proteins after four purification steps suggests that the observed complex existed in vivo. 
DISCUSSION
Although the set of enzymes under discussion is very diverse, it can be reasoned how they would all act together and facilitate the activation of MCR (Fig. 6) . Activation comprises the reduction of the Ni center of cofactor F 430 to the Ni(I) state. Activation of MCR in whole cells by either by H 2 or CO is possible (15, 19) . Electrons from the 2 H ϩ /H 2 couple represent an E m of Ϫ414 mV under growth conditions (29) . The electrons, however, can be used to reduce polyferredoxin (E m ϭ Ϫ500 mV) through the process of electron bifurcation. Electron bifurcation is performed by a complex containing Hdr/Mvh in M. marburgensis and Hdr/Mvh/Fwd and other components in Methanococcus maripaludis (29, 31) . The reductive power of these electrons, however, would not be enough to reduce the Ni in MCR. The next step is to take electrons Table 3 . The final activator fraction after four purification steps was denatured in SDS reducing sample buffer at 95°C for 5 min and loaded onto a 12% polyacrylamide gel. The gel was stained using Coomassie brilliant blue R-250 I (Bio-Rad). from ferredoxin and through coupling with ATP hydrolysis bring the potential down to the level of the Ni(I)/Ni(II) couple (estimated to be Ϫ650 mV). This can be proposed based on the presence of the Fe-protein homolog/iron sulfur cluster carrier protein that performs such a function in the nitrogenase system. The predicted sequence of the Fe protein homolog shows the presence of an ATP-binding site (Fig. 7) . The activation assay, however, does not work when ATP is present but component A2 is left out. This would indicate that A2 is responsible for delivering ATP to the Fe protein homolog and might assist in the hydrolysis. Component A2 possesses two ATP-binding domains and has sequence similarities to the ATP-binding cassette family of transport systems (32) . The Fe-protein homolog/iron sulfur cluster carrier protein is not well named since its predicted sequence shows that the [4Fe-4S]-binding site is absent (Fig. 7) . It is the combination of ATP hydrolysis and electron transfer from the nitrogenase Fe-protein's 4Fe cluster that provides the low-potential electrons for the nitrogenase reaction. Assuming that a similar process is needed for the activation of MCR, the presence of a 4Fe cluster might be essential. The cluster of the iron-sulfur flavoproteins could possibly have that function. It has been shown that the iron sulfur flavoprotein can accept electrons from polyferredoxin (33) . The MCR operon contains five genes; the mcrA, mcrB, and mcrG genes form the three subunits of MCR, while the mcrC and mcrD genes have an unknown function. It appears that the mcrC gene product might play a role in the activation of MCR. It was recently shown that CO can also activate MCR in whole cells. The CO 2 /CO couple has an E m of Ϫ520 mV, and electrons from the CO dehydrogenase complex (Cdh) are unlikely to activate MCR directly. Cdh, however, has been shown to be able to reduce the polyferredoxin (34, 35) .
Electrons for the activation of MCR can come from different known cellular processes but are most likely directly donated by polyferredoxin. Although the model predicts that MCR can be activated using H 2 as an electron source, we were not able to prove this. After the multiple purification steps, the hydrogenases in the A3a complex assumed the resting Ni-B/Ni-unready state (36) , as detected by EPR spectroscopy (not shown). The standard method to reactivate the hydrogenases (incubation under H 2 at 65°C for longer time periods of 1 to 2 h) (36) resulted in precipitation of the A3a complex, preventing testing of our model. Therefore, future research will focus on the components that are unique for the activation of MCR, which are probably the McrC proteins, the Fe-protein homolog, and the predicted iron sulfur flavoprotein. The next step will be to prove that MCR can indeed be activated by these three components using either polyferredoxin or an artificial electron donor.
